Contrary to human AD pathology, these high levels of intracellular Aβ and its high-rate metabolic turnover probably cannot result in significant membrane dysfunction and subsequent tau aggregation in the subacute course of the disease seen in the murine transgene model. This evidence concerns the gene MAPT and Alzheimer disease.